- CapitaLand Ascendas REIT reported a gross revenue of S$1.52 billion for the financial year, slightly exceeding the estimated S$1.51 billion.
- The net property income was reported at S$1.05 billion, which was just below the estimated S$1.06 billion.
- Distribution per unit for the financial year stood at S$0.1521.
- The total distributable income was S$668.8 million.
- Analyst sentiment is positive with 16 buy recommendations, and no holds or sells.
A look at CapitaLand Ascendas REIT Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 2 | |
| Resilience | 2 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
CapitaLand Ascendas REIT, a prominent industrial real estate investment trust, shows a promising long-term outlook based on its Smartkarma Smart Scores. The Trust receives a solid score of 4 for dividends, indicating a strong track record of distributing returns to investors. Additionally, with a momentum score of 4, CapitaLand Ascendas REIT is demonstrating positive market momentum and investor interest. While growth and resilience scores are slightly lower at 2, the trust’s focus on value with a score of 3 highlights its ability to deliver attractive returns relative to its price.
In summary, CapitaLand Ascendas REIT is positioned as a reliable investment option in the industrial real estate sector. With a diverse portfolio including business and science parks, high-spec industrial properties, data centers, and logistics facilities, the trust offers a compelling mix of properties. Investors can expect consistent dividend payouts, strong market momentum, and a focus on value, making CapitaLand Ascendas REIT a noteworthy player in the real estate investment trust space.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
